Elena Oldani

3.0k total citations
41 papers, 1.2k citations indexed

About

Elena Oldani is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Elena Oldani has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 17 papers in Public Health, Environmental and Occupational Health and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Elena Oldani's work include Acute Lymphoblastic Leukemia research (17 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). Elena Oldani is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). Elena Oldani collaborates with scholars based in Italy, United States and Switzerland. Elena Oldani's co-authors include Tiziano Barbui, Alessandro Rambaldi, Anna Falanga, S. Giovanelli, Marina Marchetti, Orietta Spinelli, Tamara Intermesoli, Giuseppe Rossi, Federica Delaini and Chiara Cerletti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Elena Oldani

37 papers receiving 1.2k citations

Peers

Countries citing papers authored by Elena Oldani

Since Specialization

Citations

This map shows the geographic impact of Elena Oldani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Oldani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Oldani more than expected).

Fields of papers citing papers by Elena Oldani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Oldani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Oldani. The network helps show where Elena Oldani may publish in the future.

Co-authorship network of co-authors of Elena Oldani

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Oldani. A scholar is included among the top collaborators of Elena Oldani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Oldani. Elena Oldani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06 2025 ·Leukemia Research ·(unknown), Silvia Salmoiraghi, Roberta Cavagna, Chiara Pavoni, (unknown), (unknown), Elena Oldani, Marco Frigeni, Tamara Intermesoli, Anna Grassi, Renato Bassan, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana	0
2	Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 2020 ·Frontiers in Oncology ·Francesca Patriarca, Alessandra Sperotto, Francesca Lorentino, Elena Oldani, (unknown), Miriam Isola, Alessandra Picardi, William Arcese, Giorgia Saporiti, Roberto Sorasio, Nicola Mordini, Irene Cavattoni, Maurizio Musso, Carlo Borghero, Caterina Micò, (unknown), Benedetto Bruno, Fabio Ciceri, Francesca Bonifazi	12
3	Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation 2019 ·Haematologica ·Francesca Lorentino, Nicoletta Sacchi, Elena Oldani, Valeria Miotti, Alessandra Picardi, Anna Maria Gallina, Pietro Crivello, Paolo Bernasconi, Riccardo Saccardi, Lucia Farina, Fabio Benedetti, Michela Cerno, Anna Grassi, Benedetto Bruno, Francesca Patriarca, Fabio Ciceri, Katharina Fleischhauer, Luca Vago, Francesca Bonifazi	10
4	Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 2014 ·Haematologica ·Federico Lussana, Alessandro Rambaldi, Maria Chiara Finazzi, Anja van Biezen, (unknown), Elena Oldani, Alessandra Carobbio, Stefano Iacobelli, Jürgen Finke, (unknown), Liisa Volin, T. Lamy, R Arnold, Mohamad Mohty, M. Michallet, T. de Witte, Eduardo Olavarría, Nicolaus Kröger	40
5	The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapy 2013 ·American Journal of Hematology ·Alessandro Rambaldi, Cristina Boschini, Giuseppe Gritti, Federica Delaini, Elena Oldani, Andrea Rossi, Anna Maria Barbui, Daniele Caracciolo, Marco Ladetto, Angela Gueli, (unknown), Roberto Passera, Liliana Devizzi, Caterina Patti, Alessandro M. Gianni, Corrado Tarella	53
6	Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy 2012 ·Leukemia & lymphoma ·Michael Mian, Andrés J.M. Ferreri, Andrea Rossi, Annarita Conconi, Richard Tsang, Mary Gospodarowicz, Elena Oldani, Massimo Federico, Stefano Luminari, Enrico Maria Pogliani, Fausto Rossini, María Elena Cabrera, Maurizio Martelli, Gonzalo Gutiérrez, (unknown), Franco Cavalli, Emanuele Zucca, Alessandro Rambaldi, Sergio Cortelazzo, (unknown)	11
7	Modern therapy of young and adult Ph-ALL 2012 ·PubMed ·Renato Bassan, Tamara Intermesoli, Orietta Spinelli, Elena Oldani, Alessandro Rambaldi	2
8	High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study 2011 ·Leukemia & lymphoma ·Michael Mian, Gianluca Gaïdano, Annarita Conconi, Richard Tsang, Mary Gospodarowicz, Alessandro Rambaldi, Andrea Rossi, Elena Oldani, Massimo Federico, Stefano Luminari, Monica Bellei, Enrico Maria Pogliani, Fausto Rossini, María Elena Cabrera, Maurizio Martelli, Armando López‐Guillermo, (unknown), Franco Cavalli, Emanuele Zucca, Sergio Cortelazzo	19
9	Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma 2011 ·Annals of Hematology ·Sergio Cortelazzo, Tamara Intermesoli, Elena Oldani, Fabio Ciceri, Giuseppe Rossi, Enrico Maria Pogliani, Daniele Mattei, Claudio Romani, Agostino Cortelezzi, Erika Borlenghi, (unknown), Barbara Peruta, Orietta Spinelli, Alessandro Rambaldi, Renato Bassan	28
10	Thoracic epidural analgesia in post-thoracotomy patients: comparison of three different concentrations of levobupivacaine and sufentanil 2009 ·British Journal of Anaesthesia ·(unknown), Daniela Ferrante, Elena Oldani, Gianmaria Cammarota, (unknown), Rosanna Vaschetto, Françesco Della Corte	20
11	Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09 2008 ·Haematologica ·R Bassan, Tamara Intermesoli, Elena Oldani, G. Rossi, Erika Borlenghi, (unknown), Elisabetta Terruzzi, P Fabris, E. Di Bona, Giacomo Gianfaldoni, Claudio Romani, Agostino Cortelezzi, Daniele Mattei, Orietta Spinelli, Alessandro Rambaldi	4
12	Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia 2007 ·Haematologica ·Orietta Spinelli, Barbara Peruta, (unknown), Vittoria Guerini, Aldo Salvi, (unknown), Elena Oldani, Anna Grassi, Tamara Intermesoli, Caterina Micò, Giuseppe Rossi, P Fabris, G. Lambertenghi‐Deliliers, Emanuele Angelucci, Tiziano Barbui, R Bassan, Alessandro Rambaldi	96
13	Fc RIIIA and Fc RIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab 2007 ·Haematologica ·Emanuela Carlotti, Giuseppe A. Palumbo, Elena Oldani, Daniele Tibullo, Silvia Salmoiraghi, (unknown), Josée Golay, Alessandro Pulsoni, R. Foà, Alessandro Rambaldi	76
14	Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groups 2002 ·The Hematology Journal ·Renato Bassan, (unknown), Teresa Lerede, Ursula Giussani, Elena Oldani, Maurizio Buelli, Andrea Rossi, Piera Viero, Alessandro Rambaldi, Tiziano Barbui	8
15	The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B‐cell and diffuse large B‐cell histologies 2002 ·British Journal of Haematology ·Sergio Cortelazzo, Andrea Rossi, Elena Oldani, Teresio Motta, Roberto Giardini, Pier Luigi Zinzani, Emanuele Zucca, Henry Gómez, Andrés J.M. Ferreri, Graziella Pinotti, Claudio Chini, Liliana Devizzi, Alessandro M. Gianni, Franco Cavalli, Tiziano Barbui, (unknown)	9
16	Intensification of salvage treatment with high‐dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non‐Hodgkin's lymphoma 2001 ·British Journal of Haematology ·Sergio Cortelazzo, Alessandro Rambaldi, Andrea Rossi, Elena Oldani, Michele Ghielmini, Fabio Benedetti, Corrado Tarella, (unknown), Umberto Vitolo, Massimo Di Nicola, Enrico Pogliani, F. Cavalli, Alessandro M. Gianni, Tiziano Barbui	29
17	Clinical outcome after autologous transplantation in non-Hodgkin’s lymphoma patients with high international prognostic index (IPI) 1999 ·Annals of Oncology ·Sergio Cortelazzo, Andrea Rossi, Piermario Bellavita, Elena Oldani, Piera Viero, M Buelli, Alessandro Rambaldi, Tiziano Barbui	17
18	Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma 1999 ·Annals of Oncology ·Sergio Cortelazzo, Andrea Rossi, Enrico Roggero, Elena Oldani, Emanuele Zucca, Carlo Tondini, Alberto Ambrosetti, Felice Pasini, G. Pinotti, M Bertini, Umberto Vitolo, (unknown), Luca Gianni, Franco Cavalli, Tiziano Barbui	36
19	Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor 1999 ·Blood ·Anna Falanga, Marina Marchetti, Virgilio Evangelista, Stefano Manarini, Elena Oldani, S. Giovanelli, Miriam Galbusera, Chiara Cerletti, Tiziano Barbui	131
20	The hypercoagulable state in cancer patients 1994 ·Blood Coagulation & Fibrinolysis ·Anna Falanga, Frederick A. Ofosu, Federica Delaini, Elena Oldani, (unknown), (unknown), T Barbui	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact